top of page
Mirvaso Gel (Brimonidine)
Mirvaso gel is a topical medication applied to areas of the face. Your healthcare provider may prescribe it to treat rosacea. Rosacea is a skin condition with redness and visible blood vessels in the face. Other symptoms include red pus-filled bumps, dry skin, swollen nose, enlarged pores, and bumps on the eyelids. It can be mistaken for acne. The most common sufferers are women between 30-50 with light skin. Mirvaso contains the medication brimonidine, which is a selective alpha-2 adrenergic agonist. This type of medication constricts (tightens) the blood vessels of the face, treating rosacea. Fact Table Formula C11H10BrN5 License US FDA, EU EMA Bioavailability 5 ± 3% Legal status Rx-only Chemical Name Brimonidine Elimination half-life 12 hours Dosage (Strength) 0.33% Pregnancy No Known Risk Brands Alphagan, Mirvaso Protein binding 29% PubChem CID 2435 MedlinePlus a601232 ChEBI 3175 ATC code D11AX21 DrugBank DB00484 KEGG D07540 Routes of administration Topical

Mirvaso Gel (Brimonidine)

  • Apply a small (pea-sized) amount to the face once daily. Mirvaso gel should be applied to the forehead, chin, cheeks, and nose. Do not get Mirvaso in the eyes or on the lips. Wash hands thoroughly after using this medication.
bottom of page